Spots Global Cancer Trial Database for neulasta
Every month we try and update this database with for neulasta cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM | NCT00612989 | Glioblastoma Gliosarcoma | Temodar and O6-... | 18 Years - | Duke University | |
| Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma | NCT00067639 | Multiple Myelom... | Pegfilgrastim (... Apheresis | 18 Years - | M.D. Anderson Cancer Center | |
| ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer | NCT00261313 | Breast Cancer | Neulasta Aranesp | 18 Years - | Amgen | |
| Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) | NCT01657331 | Hodgkin Lymphom... Anaplastic Larg... | Brentuximab Ved... Bendamustine Neulasta | 18 Years - | Columbia University | |
| Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy | NCT01437488 | Urothelial Carc... | Cabazitaxel Neulasta CT Scan Blood Draw | 18 Years - | Thomas Jefferson University | |
| Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma | NCT00067639 | Multiple Myelom... | Pegfilgrastim (... Apheresis | 18 Years - | M.D. Anderson Cancer Center | |
| Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen | NCT00074165 | Brain and Centr... Drug/Agent Toxi... Lymphoma Thrombocytopeni... | Rituxan Cyclophosphamid... Etoposide Etoposide phosp... Carboplatin Sodium thiosulf... Neupogen Neulasta Cytarabine | 18 Months - 75 Years | OHSU Knight Cancer Institute | |
| A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer | NCT01076504 | Extensive-Stage... | Amrubicin Carboplatin Pegfilgrastim | 18 Years - | SCRI Development Innovations, LLC | |
| Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma | NCT00068393 | Metastatic Rena... Renal Cell Carc... | Doxorubicin Gemcitabine G-CSF (granuloc... Neulasta | 18 Years - | Eastern Cooperative Oncology Group | |
| Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma | NCT00068393 | Metastatic Rena... Renal Cell Carc... | Doxorubicin Gemcitabine G-CSF (granuloc... Neulasta | 18 Years - | Eastern Cooperative Oncology Group | |
| Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | NCT01648322 | Breast Cancer Neutropenia | F-627 Neulasta® (pegf... | 18 Years - 74 Years | EVIVE Biotechnology | |
| Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma | NCT00067639 | Multiple Myelom... | Pegfilgrastim (... Apheresis | 18 Years - | M.D. Anderson Cancer Center | |
| ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer | NCT00261313 | Breast Cancer | Neulasta Aranesp | 18 Years - | Amgen | |
| Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM | NCT00612989 | Glioblastoma Gliosarcoma | Temodar and O6-... | 18 Years - | Duke University | |
| Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide | NCT00283621 | Sarcoma | Aranesp (darbep... Neulasta (pegfi... Adriamycin Ifosfamide | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| NOLAN: Naproxen or Loratadine and Neulasta | NCT01712009 | Bone Pain in St... | Naproxen Loratadine Pegfilgrastim Chemotherapy | 18 Years - 100 Years | Amgen | |
| A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer | NCT01076504 | Extensive-Stage... | Amrubicin Carboplatin Pegfilgrastim | 18 Years - | SCRI Development Innovations, LLC | |
| Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim | NCT01752907 | Breast Cancer | General Educati... Bone Pain Educa... | 18 Years - 99 Years | Amgen | |
| Dacarbazine and Carmustine in Metastatic Melanoma | NCT01692691 | Melanoma Metast... | Dacarbazine Carmustine Neulasta | 18 Years - | Western Regional Medical Center | |
| Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | NCT01648322 | Breast Cancer Neutropenia | F-627 Neulasta® (pegf... | 18 Years - 74 Years | EVIVE Biotechnology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
